Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata/QA update with no visible changes to trial details.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page footer now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing v3.4.0. This appears to be a minor administrative update with no impact on the study information presented.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page now includes a glossary toggle and minor wording/case changes in metadata labels (e.g., 'Last Update...' and 'No FEAR Act Data') along with a new revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.